Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects. (Q40862084)
Jump to navigation
Jump to search
scientific article published on March 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects. |
scientific article published on March 1998 |
Statements
Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects (English)
Perricaudet M
1 reference
Fernandez N
Duffour MT
Tursz T
Zitvogel L